Homo sapiens Protein: SAG | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||
InnateDB Protein | IDBP-292885.5 | ||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||
Gene Symbol | SAG | ||||||||||||||||||||||
Protein Name | S-antigen; retina and pineal gland (arrestin) | ||||||||||||||||||||||
Synonyms | RP47; S-AG; | ||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||
Ensembl Protein | ENSP00000386444 | ||||||||||||||||||||||
InnateDB Gene | IDBG-83475 (SAG) | ||||||||||||||||||||||
Protein Structure | |||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||
Function | Arrestin is one of the major proteins of the ros (retinal rod outer segments); it binds to photoactivated- phosphorylated rhodopsin, thereby apparently preventing the transducin-mediated activation of phosphodiesterase. | ||||||||||||||||||||||
Subcellular Localization | |||||||||||||||||||||||
Disease Associations | Night blindness, congenital stationary, Oguchi type 1 (CSNBO1) [MIM:258100]: A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia. Congenital stationary night blindness Oguchi type is an autosomal recessive form associated with fundus discoloration and abnormally slow dark adaptation. {ECO:0000269PubMed:7670478}. Note=The disease is caused by mutations affecting the gene represented in this entry.Retinitis pigmentosa 47 (RP47) [MIM:613758]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269PubMed:9565049}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||||||
Tissue Specificity | Retina and pineal gland. | ||||||||||||||||||||||
Comments | |||||||||||||||||||||||
Interactions | |||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 4 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
|
||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||
InterPro |
IPR000698
Arrestin IPR011021 Arrestin-like, N-terminal IPR011022 Arrestin C-terminal-like domain IPR014756 Immunoglobulin E-set |
||||||||||||||||||||||
PFAM |
PF00339
PF02752 |
||||||||||||||||||||||
PRINTS |
PR00309
|
||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||
SMART |
SM01017
|
||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||
Modification | |||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||
SwissProt | P10523 | ||||||||||||||||||||||
PhosphoSite | PhosphoSite-P10523 | ||||||||||||||||||||||
TrEMBL | E7ESX4 | ||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||
Entrez Gene | 6295 | ||||||||||||||||||||||
UniGene | Hs.32721 | ||||||||||||||||||||||
RefSeq | NP_000532 | ||||||||||||||||||||||
HUGO | HGNC:10521 | ||||||||||||||||||||||
OMIM | 181031 | ||||||||||||||||||||||
CCDS | CCDS46545 | ||||||||||||||||||||||
HPRD | 01625 | ||||||||||||||||||||||
IMGT | |||||||||||||||||||||||
EMBL | AC013726 DQ980620 U70962 U70963 U70964 U70965 U70966 U70967 U70968 U70969 U70970 U70971 U70972 U70973 U70974 U70975 U70976 X12453 | ||||||||||||||||||||||
GenPept | AAC50992 AAY14861 ABJ97141 CAA30984 | ||||||||||||||||||||||